Current models for AD are largely transgenic animals, which overexpress mutant humanamyloid precursor protein (APP), tau, or presenilin 1.53, 54 Those models have shedlight on the role of aggregation of tau or amyloid β2 in interference withessential cellular mechanisms. The gene discussed is MAPT; the disease is Alzheimer disease.